Bill > S5051

This bill, the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020, aims to amend the Social Security Act to provide Medicare coverage for multi-cancer early detection screening tests. These tests, which are approved or cleared by the Food and Drug Administration (FDA), are used to detect cancer across multiple cancer types at an early stage. The bill establishes these multi-cancer early detection screening tests as a covered benefit under Medicare, allowing beneficiaries to access them without unnecessary delay once they are approved by the FDA. The bill also sets a frequency limit of one test per 11-month period and clarifies that coverage of these tests does not affect coverage for other cancer screening tests, such as those for breast, cervical, colorectal, lung, or prostate cancer.